Spiroindolines identify the vesicular acetylcholine transporter as a novel target for insecticide action
The efficacy of all major insecticide classes continues to be eroded by the development of resistance mediated, in part, by selection of alleles encoding insecticide insensitive target proteins. The discovery of new insecticide classes acting at novel protein binding sites is therefore important for...
Saved in:
Published in | PloS one Vol. 7; no. 5; p. e34712 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Public Library of Science
01.05.2012
Public Library of Science (PLoS) |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The efficacy of all major insecticide classes continues to be eroded by the development of resistance mediated, in part, by selection of alleles encoding insecticide insensitive target proteins. The discovery of new insecticide classes acting at novel protein binding sites is therefore important for the continued protection of the food supply from insect predators, and of human and animal health from insect borne disease. Here we describe a novel class of insecticides (Spiroindolines) encompassing molecules that combine excellent activity against major agricultural pest species with low mammalian toxicity. We confidently assign the vesicular acetylcholine transporter as the molecular target of Spiroindolines through the combination of molecular genetics in model organisms with a pharmacological approach in insect tissues. The vesicular acetylcholine transporter can now be added to the list of validated insecticide targets in the acetylcholine signalling pathway and we anticipate that this will lead to the discovery of novel molecules useful in sustaining agriculture. In addition to their potential as insecticides and nematocides, Spiroindolines represent the only other class of chemical ligands for the vesicular acetylcholine transporter since those based on the discovery of vesamicol over 40 years ago, and as such, have potential to provide more selective tools for PET imaging in the diagnosis of neurodegenerative disease. They also provide novel biochemical tools for studies of the function of this protein family. |
---|---|
Bibliography: | Conceived and designed the experiments: JDW AS R. Clover FGPE SS MPR JC PM L-PM RSR DJH TP FC PAW. Performed the experiments: AS R. Clover CS SS MS AJF PC TF EAH. Analyzed the data: AS R. Clover SS FGPE MPR JDW JC PM L-PM RSR DAH TP FC PAW EH AJF AJC R. Currie CS. Wrote the paper: FGPE JC AS SS. Current address: Syngenta Biotechnology Inc., Research Triangle Park, North Carolina, United States of America Current address: Scynexis, Inc., Research Triangle Park, North Carolina, United States of America Current address: Drug Discovery Division, Laboratorios Almirall S.A., Barcelona, Spain |
ISSN: | 1932-6203 1932-6203 |
DOI: | 10.1371/journal.pone.0034712 |